n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, September 24th, 2015

The QualityStocks
Daily Stock List

graphic
graphic

ImmuDyne, Inc. (IMMD)

PennyStocks24, Buzz Stocks, Planet Penny Stocks, Penny Pick Finders, SecretStockPromo, PennyStockProphet, and StockOnion reported previously on ImmuDyne, Inc. (IMMD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

ImmuDyne, Inc. is a science-based wellness & healthcare company that lists on the OTC Markets’ OTCQB. The Company has developed proprietary topical and oral delivery technologies, with a number of new market opportunities. In addition, ImmuDyne manufactures and sells yeast beta-1,3/1,6 glucan for oral and topical uses. The Company sells its products directly to consumers, and also to pharmaceutical, nutraceutical, and consumer product companies. Founded in 1987, ImmuDyne has offices in Mt. Kisco, New York; Tampa, Florida; and Florence, Kentucky.

By way of a highly complex, proprietary process that utilizes best-in-class technology, ImmuDyne can extract highly purified beta-1,3/1,6-D-glucan from the cell walls of Saccaharomyces cerevisiae. The Company indicates that it is well-established in the scientific community that beta-glucans are powerful activators of the innate immune response. Recent studies indicate that yeast beta-1,3/1,6-D-glucans can also activate adaptive immune responses.

ImmuDyne’s products include iNR Wellness™. iNR Wellness is a nutritional supplement. It naturally supports the immune system with PURACERE™ and a vitamin C complex. Products also include iNR Wellness MD. This is a nutritional supplement. It naturally empowers one’s immune system with PURACERE™, IP-6, and a vitamin C complex.

In addition, ImmuDyne’s product line-up includes iNR Strength™. iNR Strength is a nutritional supplement. It naturally supports the immune system with PURACERE™ and antioxidants.

Furthermore, the Company has its ImmuDyne Skin Care Essentials™. Skin Care Essentials ™ is a patented two-step advanced skin care treatment. It contains the innovative natural ingredient Beta-1,3/1,6-D-glucan.

Last week, ImmuDyne announced that Mr. Sven Rohmann M.D., PhD, M.B.A. has joined its Board of Directors. Dr. Rohmann previously spent 10 years at Merck Serono. He has an excellent record of accomplishment across scientific, clinical, and commercial markets.

Essentially, ImmuDyne’s strategy is to create new market spaces within the wellness industry via the launch of clinically researched, doctor recommended immune support products and services.

ImmuDyne, Inc. (IMMD), closed Thursday's trading session at $0.095, even for the day, on 390 volume with 1 trade. The average volume for the last 60 days is 12,512 and the stock's 52-week low/high is $0.03/$0.23.

Cubic Energy, Inc. (CBNR)

AwesomePennyStocks reported earlier on Cubic Energy, Inc. (CBNR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 1978, Cubic Energy, Inc. is an independent energy company headquartered in Dallas, Texas. It engages in the development and production of, and exploration for, crude oil and natural gas. The concentration of the Company’s oil and gas assets and activities are mainly in Texas and in Louisiana. Cubic Energy’s share’s trade on the OTC Markets Group’s OTCQB.

Cubic’s multi-dimensional emphasis is on the integration of earth sciences, engineering and financial management in oil and gas exploration and development. Its strategy regarding its asset development efforts is to position Cubic Energy in a low risk opportunity while building main stream high yield reserves.

The Company has acreage in northwest Louisiana. It has positions in DeSoto and Caddo Parishes. This puts Cubic in a low risk environment with the Cotton Valley and Haynesville Shale formations. In addition, it gives the Company the potential to exploit added commercial horizons, which Cubic believes can add value to its bottom line. Cubic has 55 gas wells in Louisiana - in Caddo Parish and DeSoto Parish.

Cubic Energy also has its East Texas Hilltop assets, acquired in 2013. The Company acquired prolific Bossier gas assets. Cubic has identified opportunities to commercially produce oil from the Cretaceous zones. Cubic Energy’s Texas assets include 28 gas wells and 19 oil wells, situated in Leon County. Cubic is the owner of the wells positioned in Leon County. The wells are operated by affiliate Fossil Operating, Inc.

In December 2014, Cubic Energy reported the status of the sustained development of its non-operated northwest Louisiana acreage. The Company previously announced its subsidiary, Cubic Louisiana, LLC, had elected to participate in the drilling and completion of five horizontal Haynesville Shale wells. Nonetheless, the operator decided that four wells would be drilled instead, because of efficiencies. Cubic Energy has an approximate 27 percent working interest (WI) in each of the four wells situated in Caddo Parish.

Cubic Energy, Inc. (CBNR), closed Thursday's trading session at $0.0041, up 2.50%, on 2,200 volume with 1 trade. The average volume for the last 60 days is 63,897 and the stock's 52-week low/high is $0.003/$0.17.

Integrated Environmental Technologies Ltd. (IEVM)

Momentum Traders, HotStockChat, SmallCapVoice, Stock Guru, and OTC Picks reported on Integrated Environmental Technologies Ltd. (IEVM), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Integrated Environmental Technologies Ltd. operates via its wholly-owned operating subsidiary, I.E.T., Inc.  I.E.T is a manufacturing company that designs and builds equipment, which incorporates unique technologies centering on the enhancement of the environment and the health, safety, and wellbeing of present and future generations. I.E.T. produces products that have been tested, proven, and accepted by private, state, and federal agencies. OTCQB-listed, Integrated Environmental Technologies is based in Little River, South Carolina.

All of the Company’s products and services are marketed and sold under the umbrella brand name, EcoTreatments™. Its I.E.T. subsidiary has approval by the US Food and Drug Administration (FDA) for applications of the Company’s proprietary extraction technology being introduced into the healthcare, medical, nutraceutical, and pharmaceutical markets.

I.E.T. sells anolyte disinfecting solution under the EcaFlo™ and Excelyte® brand names. The EcaFlo™ Division designs, manufactures, markets, sells, and installs proprietary Electro-Chemical Activation (ECA) equipment in the U.S. and globally. The innovative design of EcaFlo™ equipment is to produce EcaFlo™ Anolyte and Catholyte solutions with predictable and carefully controlled properties. The EcaFlo™ equipment utilizes an electrolytic process called electrochemical activation to reliably produce environmentally responsible solutions for cleaning, sanitizing, and disinfecting.

EcaFlo™ Anolyte and Excelyte® solutions are Environmental Protection Agency (EPA)-registered hard surface disinfectants and sanitizers. They have approvals for hospital-level use and for use as a biocide in oil and gas drilling. EcaFlo™ equipment employs a proprietary operating system. This system has a simple touch screen interface to control the unit's PLC and internal components.

The Company also sells a cleaning solution under the Catholyte Zero™ brand name. Catholyte Zero™ solutions are an environmentally friendly cleanser and degreaser for janitorial, sanitation, and food processing uses. Integrated Environmental Technologies announced in 2014 that it received approval from the EPA to market a new Excelyte™ product called Excelyte VET, which can be used to prevent Canine distemper.

The Company reported in January 2014 that it identified the oil and gas market as a market of major potential. Concerning healthcare, it reported that a second major market lies in the disinfection of hospitals, nursing homes, and clinics. The Company has established a production facility in Artesia, New Mexico.

Recently, Integrated Environmental Technologies announced that it entered into a master service agreement with EP Energy Corporation (EP), an independent exploration and production company (Houston, Texas) to provide Excelyte® well maintenance treatments on EP's oil and gas wells in the U.S.  This was the conclusion of a six-month Excelyte® testing and evaluation process conducted by EP in which Excelyte® well maintenance treatments were performed on four EP test wells in the Uinta Basin, with the results being compared to other competitive products.  The Company stated that these results showed that Excelyte® was an effective biocide and hydrogen sulfide eliminator and was more cost effective than competing products.

Integrated Environmental Technologies Ltd. (IEVM), closed Thursday's trading session at $0.039, up 0.26%, on 201,500 volume with 4 trades. The average volume for the last 60 days is 301,891 and the stock's 52-week low/high is $0.0135/$0.10.

Boston Therapeutics, Inc. (BTHE)

RedChip, TaglichBrothers, and Stock News Now reported earlier on Boston Therapeutics, Inc. (BTHE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

OTC BB-listed Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. Its product pipeline focuses on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases. In addition, the Company developed and markets SUGARDOWN®. This is a non-systemic complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose. Boston Therapeutics is based in Manchester, New Hampshire.

The Company’s product pipeline includes BTI-320. This is a non-systemic chewable complex carbohydrate-based compound. The design of it is to reduce post-meal glucose elevation. BTI-320 is a proprietary polysaccharide. It is to be taken before meals.

BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, decreasing the availability of glucose for absorption into the bloodstream. Boston Therapeutics has entered into a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320.

The Company’s product pipeline also includes IPOXYN. This is an injectable anti-necrosis drug. The design of it initially is to treat lower limb ischemia associated with diabetes.

Boston Therapeutics announced earlier this year that its affiliate Advance Pharmaceutical initiated the SUGARDOWN® clinical trial in Hong Kong. Advance Pharmaceutical will evaluate the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. Dr. Andria Luk and Dr. Juliana CN Chan, PRCP are the lead principal investigators. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital.

Last week, Boston Therapeutics announced that Advance Pharmaceutical is conducting a clinical trial at The Chinese University of Hong Kong (CUHK) to evaluate BTI-320 in subjects who are pre-diabetic. The clinical trial has enrolled 56 of the planned 60 pre-diabetic patients. Furthermore, the interim clinical analysis in the proof of concept trial demonstrate up to 77 percent reduction in Glucose and up to 27 percent in Fructose.

Boston Therapeutics, Inc. (BTHE), closed Thursday's trading session at $0.10, down 23.08%, on 31,885 volume with 3 trades. The average volume for the last 60 days is 31,151 and the stock's 52-week low/high is $0.08/$0.80.

Ener-Core, Inc. (ENCR)

StockOodles and Stock News Now reported on Ener-Core, Inc. (ENCR), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

OTC Bulletin Board-listed Ener-Core, Inc. designs, develops, manufactures and has commercially deployed innovative systems, which generate base-load, clean power from polluting waste gases including methane. The Company’s patented Power Oxidizer turns one of the most potent pollution sources into a profitable source of base-load clean energy. Ener-Core has its corporate headquarters in Irvine, California.

The Company’s technology offers an alternative to the flaring (burning) of gaseous pollution. This is while generating operating efficiencies and reducing the costs of compliance with environmental regulations. Ener-Core offers an array of platforms. These include the 250kW Ener-Core Powerstation EC250 (EC250), the Ener-Core Power Oxidizer 333 KW Powerstation (EC333) and the 2MW Ener-Core Powerstation KG2-3GEF/PO, the larger counterpart.

The patented Ener-Core Power Oxidizer and associated oxidation process (when paired with gas turbines) allows the conversion of these gases into useful heat and power with the lowest known associated emissions. With the Ener-Core Power Oxidizer matched to gas turbines, the Company offers systems with fuel flexibility and pollution control for power generation. Moreover, the Power Oxidizer can be customized for integration with larger existing power generation systems to offer premier pollution control and achieve zero emissions.

This month, Ener-Core announced that it received a purchase order totaling $900,000 from the Advanced Power & Energy Program (APEP) of the University of California, Irvine. This is for the installation of Ener-Core’s 250kW Powerstation EC250 at the closed Santiago Canyon Landfill in Orange County. The installed Powerstation will utilize the low-quality gas created from solid waste decomposition to generate electricity for Orange County Waste & Recycling site operations.

This is the second purchase order Ener-Core has received in roughly one month. It is following the receipt of a purchase order from Dresser-Rand in early August for the delivery and installation of two of Ener-Core’s larger-scale two-megawatt Power Oxidizers to be coupled with the Dresser-Rand KG2-3GEF two-megawatt gas turbine generators for Pacific Ethanol’s Stockton, California plant.

Ener-Core, Inc. (ENCR), closed Thursday's trading session at $6.00, down 6.25%, on 1,984 volume with 13 trades. The average volume for the last 60 days is 2,184 and the stock's 52-week low/high is $0.12/$6.70.

graphic

The QualityStocks
Company Corner

graphic
graphic

Avant Diagnostics, Inc. (AVDX)

The QualityStocks Daily Newsletter would like to spotlight Avant Diagnostics, Inc. (AVDX). Today, Avant Diagnostics, Inc. closed trading at $0.278, up 11.20%, on 9,291 volume with 6 trades. The stock’s average daily volume over the past 60 days is 2,179, and its 52-week low/high is $0.2003/$1.95.

Avant Diagnostics, Inc. began calibration testing in preparation for the validation study of OvaDx®, which will be used to support a pre-Submission package to the United States Food and Drug Administration. Avant expects to have the calibration testing completed within 30 days. Once the calibration testing is completed, Avant plans to test the previously purchased set of ovarian cancer specimens, including serial sets obtained from women diagnosed previously with ovarian cancer, which will serve as the validation study and form the basis of the pre-Submission package that will be submitted to FDA for review and comment prior to the commencement of the OvaDx® 510(k) trial.

Avant Diagnostics, Inc. (AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company's first test, OvaDx®, is a sophisticated microarray-based test designed to detect pre-symptomatic ovarian cancer by measuring the activation of the immune system in blood samples in response to early stage ovarian tumor cell development.

In clinical development, OvaDx has indicated high sensitivity and specificity for all types and stages of ovarian cancer, including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous and ovarian adenocarcinoma. Upon FDA approval, Avant plans to offer its diagnostic product as an elective test for women seeking greater wellness, as well as those in the elevated risk category for ovarian cancer.

OvaDx is also expected to be used by doctors to advance the forefront of ovarian cancer treatment, promoting the utilization of improved surgical options and more effective chemotherapies by serving as a supplement to existing tests, such as CA-125, OVA1® and transvaginal ultrasound. In this way, Avant's innovative product will promote earlier diagnoses and, as a result, improved survival rates for patients with ovarian cancer.

As it continues to seek FDA approval for its groundbreaking diagnostic technology, Avant is poised to promote considerable growth in the ovarian cancer market, addressing what is currently the most deadly cancer of the female reproductive system. The company will lean on the industry experience of its management team in order to continue positioning itself for long-term success in the medical diagnostic market. Disclaimer

Avant Diagnostics, Inc. Company Blog

Avant Diagnostics, Inc. News:

Avant Diagnostics Inc. Commences OvaDx(R) Ovarian Cancer Test Calibration in Preparation for FDA Submission

Avant Diagnostics, Inc. Appoints Marcum LLP as Its New Independent Registered Public Accounting Firm

Avant Diagnostics, Inc. Retains Sichenzia Ross Freidman Ference LLP as Its Corporate Counsel

Hemp, Inc. (HEMP)

The QualityStocks Daily Newsletter would like to spotlight Hemp, Inc. (HEMP). Today, Hemp, Inc. closed trading at $0.056, up 1.82%, on 2,179,538 volume with 111 trades. The stock’s average daily volume over the past 60 days is 631,354, and its 52-week low/high is $0.05/$1.00.

Hemp, Inc. was acknowledged today by Stevia Corp and Real Hemp for its assistance helping to promote the recent unveiling of a searchable digital library consisting of more than 30 years of peer reviewed scientific research publications focused on the cannabis plant. The searchable research library contains some of the most important research ever published on the cannabis plant, with specific concentration on glandular trichome development.

Hemp, Inc. (HEMP) is engaged in the research and development of all things made of industrial hemp. From fabric, paper, cosmetics, food and jewelry to pulp, fuel, paints and more, the application of hemp represents a myriad of possibilities. The company strategizes to recognize the profits that could be made in making the world a better place through the industrial commercialization of this resource.

Hemp, Inc. subsidiaries include Industrial Hemp Manufacturing, LLC, which will soon be offering DrillWall™ for maintaining the seals on drilling for water, oil, gas and any other liquid or gas; and The Industrial Hemp and Medical Marijuana Consulting Company, Inc., which pulls pertinent market information from a vast network of professionals, specialists and experts from various niches of the hemp industry.

Las Vegas-based Hemp, Inc. conducts its operations through its 70,000-square-foot processing plant and decortication line of equipment, which is useful manufacturing more than 50,000 commercial products. The company's current line of offerings include hemp-infused body candles, shampoo and conditioner, smoothies, jewelry, healing oils, twine, lip balm and skin moisturizers.

Hemp products are used all over America every day and are sold in the largest and most respected stores. Not to be confused with marijuana, hemp does not contain psychoactive compounds and is legal in the United States and most of the world. Hemp, Inc.'s mission is to educate the public on this important differentiation while working to expand corporate infrastructure and invest in profitable, legal and diversified ventures poised to bring reward and value to shareholders. Disclaimer

Hemp, Inc. Company Blog

Hemp, Inc. News:

Hemp, Inc. (HEMP) Publicly Acknowledged By Stevia Corp. (STEV) For Helping To Publicize 30 Years of Ground Breaking Cannabis Research

Hemp, Inc. Subsidiary's COO, David Schmitt, Elected to the North Carolina Industrial Hemp Association (NCIHA) Board of Directors

Hemp, Inc. Reports 2nd Quarter 2015 Financial Results

Fresh Promise Foods, Inc. (FPFI)

The QualityStocks Daily Newsletter would like to spotlight Fresh Promise Foods, Inc. (FPFI). Today, Fresh Promise Foods, Inc. closed trading at $0.0003, even for the day, on 12,118,510 volume with 17 trades. The stock’s average daily volume over the past 60 days is 15,605,723, and its 52-week low/high is $0.0001/$0.165.

Fresh Promise Foods, Inc. today announced the launch of Harvest Soul Blended Juices, a line of 4 blended fruit and vegetable juices, along with the Company's largest purchase order to date. Harvest Soul Organic Blended Juices are a delicious line of fiber-rich blended juices, not pressed, packed with superfood vegetables and fruits, like spinach, pineapple, blueberries, kale and celery. Blended juices are never pressed, so beneficial fiber is retained making these functional and organic juices supportive of a healthy lifestyle.

Fresh Promise Foods, Inc. (FPFI) is a consumer products and marketing company operating in the high-margin multi-billion dollar health and wellness food and beverage sectors. The company sets itself apart from the competition by marrying innovative technology and product development with perceptive marketing and sales service strategy.

Through wholly-owned subsidiary Harvest Soul, Inc., FPFI produces the world's first USDA organic, Non-GMO Project verified chewable juice products. Utilizing some of the world's healthiest ingredients, the company creates a nutritionally-dense combination of fiber-rich vegetables and fruits mixed with tasty bits of chewable seeds, nuts and berries. By encouraging chewing during consumption, these revolutionary juices have been shown to jumpstart digestion and promote improved nutrient absorption.

Since launching its chewable juice products online in December 2014, the company has made considerable progress in expanding upon its market presence. As of its latest update, FPFI had secured placement in all 32 Whole Foods Market locations in its five-state southern region and entered into a distribution agreement with San Francisco-based Optimum Sales in order to expand its distribution footprint to include the West Coast and Pacific Northwest.

According to a report by the Organic Trade Association, sales of organic food and non-food products in the United States exceeded $39 billion in 2014, representing an increase of 11.3 percent over the previous year. As FPFI continues to expand its national distribution network, the company should be in a strong strategic position to leverage this market performance in order to promote sustainable growth.

FPFI is also committed to expanding its presence in the organic foods industry by investing in businesses that have identified a unique niche in the health and wellness sector. Through its ventures and emerging brands segment, the company looks to provide senior management support to pre-revenue or early-stage firms with an established leadership team and a passion for food, health and wellness. Disclaimer

Fresh Promise Foods, Inc. Company Blog

Fresh Promise Foods, Inc. News:

Fresh Promise Foods' Harvest Soul Division Launches New Organic GMO-Free Blended Juice Line, Procures Largest Purchase Order to Date

Fresh Promise Foods' Harvest Soul to Unveil Two New Organic Chewable Juice Flavors at Natural Products Expo East 2015

Fresh Promise Foods, Inc. (FPFI) CEO Featured in Exclusive QualityStocks Interview

The Aristocrat Group Corp. (ASCC)

The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $1.24, on 33,863 volume with 90 trades. The stock’s average daily volume over the past 60 days is 20,182, and its 52-week low/high is $0.51/$6.00.

Aristocrat Group Corp. reported today on how, as the U.S. marketplace becomes ever more crowded with outlandish flavored vodkas, ASCC’s Ultra-Premium Handcrafted RWB Vodka has become one of the most awarded American-made vodkas, simply by focusing on quality ingredients and premium distillation. Created using only the highest quality Idaho russet potatoes and pure, mountain spring water, RWB is distilled in the American heartland using a unique four-column distillation process before being filtered five times to achieve a perfectly balanced vodka that has been subjected to the most exacting standards in the industry.

The Aristocrat Group Corp. (ASCC) is a brand management company specializing in the discovery and promotion of unique brands with mass market appeal. The company strategizes to capitalize on unprecedented brand-building opportunities, and is working to build a portfolio of successful brands to compete alongside industry leaders like Moet Hennessy, Louis Vuitton, Diageo PLC, and Brown-Forman Corp.

Luxuria Brands, an ASCC subsidiary, is tasked with brand management and sustainability, specifically in the beverage alcohol sector, where the company will develop and market brands using strategic, cross-cultural branding initiatives that engage businesses and consumers. Vodka boasts a significantly high market share, accounting for 25 percent of all distilled spirits sold in the United States. What this means for ASCC investors is that they have a remarkable chance to capitalize on a proven commodity and business model for distribution.

To this accord, ASCC's current portfolio of premium luxury goods brands includes top-shelf distilled spirits like RWB Vodka, an ultra-premium handcrafted spirit that has already met remarkable success, including multiple awards. The market for vodka is estimated to be at almost 60 million cases per year in the United States alone, and beverages priced at a premium level are garnering top-dollar returns for businesses and investors. Strategizing to capitalize on this powerful sector, ASCC plans to debut a second lifestyle vodka brand later this year.

ASCC's experienced and visionary management team is committed to creating a solid foundation for innovative technologies and models, ranging from mobile couponing to social engagement, that drive business forward. Building on its established presence in the lucrative beverage alcohol sector, ASCC is emerging as a trusted platform where fledgling ideas turn into commercial successes. Disclaimer

The Aristocrat Group Corp. Company Blog

The Aristocrat Group Corp. News:

ASCC: RWB Vodka Defies Trends with its Ultra-Premium Recipe for Success

ASCC: Awards Tally Makes RWB One of America’s Best Vodkas

ASCC Uses Local Ingredients and Old-Fashioned Craftsmanship to Produce America’s Vodka

Cherubim Interests, Inc. (CHIT)

The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.0028, up 27.27%, on 14,699,051 volume with 108 trades. The stock’s average daily volume over the past 60 days is 789,141, and its 52-week low/high is $0.0017/$0.5535.

Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.

The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.

Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.

Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer

Cherubim Interests, Inc. Company Blog

Cherubim Interests, Inc. News:

Cherubim Interests, Inc. (CHIT) Announces Engagement of QualityStocks Investor Relations Services

Cherubim Interests Inc. Acquires License to Enter Controlled Environment Agriculture Industry

Cherubim Interests Inc. Announces Completion of Corporate Actions

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(CHIT)

2.

Investors Alley
(PGSY)

3.

INO.com Market Report
(VBLT)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251